From immunomodulators (IMiDs) to cereblon E3 ligase modulator (CELMoDs): the evolution of cereblon modulators in lymphoma therapy.
Saved in:
| Title: | From immunomodulators (IMiDs) to cereblon E3 ligase modulator (CELMoDs): the evolution of cereblon modulators in lymphoma therapy. |
|---|---|
| Authors: | Saha A; Department of Hematology Oncology, University of Alabama at Birmingham, Birmingham, AL, USA., Jhaveri K; Department of Hematology Oncology, Indiana University School of Medicine, Indianapolis, IN, USA., Perini GF; Einstein Hospital Israelita, Sao Paulo, Brazil., Chavez JC; Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA. |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2026 Jun; Vol. 67 (7), pp. 1479-1491. Date of Electronic Publication: 2026 May 19. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1029-2403 |
|---|---|
| DOI: | 10.1080/10428194.2026.2662494 |
